Patent · US Active

Cancer therapies and diagnostics

US10822374B2 · kind B2 · utility

3Cited by
5References
29Claims
0Family size

Assignees

Inventors

Key dates

Filing dateNov 14, 2011
Grant dateNov 3, 2020
Priority date—
Expiry dateNov 11, 2032

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61P35/00
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

Compositions and methods for increasing p53-dependent transcriptional activity in a cell.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.